Call Options Transactions Made in Q4 2024 in Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT) during Q4 2024. The information is specifically focused on institutions that hold call options of Arcutis Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Stem Point Capital LP
New York, NY |
BUY
|
CALL |
1.33M+ 530.0% |
$11M - $19.9M
|
1.58M
$20.5M
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
61.5K+ 34.17% |
$511K - $922K
|
242K
$3.14M
|
|
|
Feb 13, 2025
Q4 2024
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
CALL |
17.8KNew |
$148K - $267K
|
17.8K
$232K
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
CALL |
-15.4K- 24.44% |
$128K - $231K
|
47.6K
$620K
|
|
|
Feb 14, 2025
Q4 2024
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
CALL |
-25K- 23.81% |
$208K - $375K
|
80K
$1.04M
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-29.3K- 32.66% |
$243K - $439K
|
60.4K
$786K
|